Navigation Links
[video] Michael DePasquale, CEO of BIO-key International, Inc., Discusses Q2 2008 Revenue Growth on WallSt.net's 3-Minute Press Show
Date:7/30/2008

NEW YORK, July 30 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger- based biometric identification solutions, today announced that the company's Chief Executive Officer, Michael DePasquale, is featured in an exclusive interview on WallSt.net's 3-Minute Press Show.

The interview gives viewers an overview of the company, and the significance of the company's latest press release.
To view the clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/BKYI/182/794

About BIO-key:

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 750 police departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for law enforcement. (http://www.bio-key.com)

About WallStreet Direct, Inc.

WallStreet Direct, Inc. operates WallSt.net (http://www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (

SOURCE BIO-key International, Inc.; WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinsons Disease
2. Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinsons
3. Neuroscientist Michael Gazzaniga awarded Humboldt Prize
4. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
5. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
6. American Society for Microbiology honors Michael Bruce Zwick
7. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
8. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
9. BIO-key(R) Issues Open Letter to Shareholders
10. Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software
11. BIO-key(R) Awarded $2 Million Biometric Contract by Multi-National Company

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...assistant professors recently received funding fro...e research beneficial to understanding the environ...pher Blackwood, assistant professor in the Departm...support two separate research projects. , His fi...Communities and Functions from the Leaf to the Lan...
(Date:11/24/2009)...new doors to understanding how sounds associated w...e mammal or if they hear it at all. , The same ... NASA uses to detect flaws in the space shuttle,s ...ists to peek inside the giant head of a whale. The...plicas of a whale,s hearing anatomy using a breakt...
(Date:11/24/2009)...College of Medical Toxicology (ACMT) have signed a...he Journal of Medical Toxicology (JMT), the offi... It was previously published by the University of...Toxicology , an international, peer-reviewed journ...tice of medical toxicology. The quarterly journal...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2PETAs push for changes in USDA testing pays off for animals 10415 1CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 1CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 2CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 3CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 4CEL SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL 2000 Has Potential to Slow Damage Caused by Rheumatoid Ar 59750 1CEL SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL 2000 Has Potential to Slow Damage Caused by Rheumatoid Ar 59750 2CEL SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL 2000 Has Potential to Slow Damage Caused by Rheumatoid Ar 59750 3CEL SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL 2000 Has Potential to Slow Damage Caused by Rheumatoid Ar 59750 4
... across which information crosses between nerve ce...ns, called plasticity, play a vital role in both m...ow nerve signals propagate. , Assistant profess...ab that studies learning and memory in fruit flies...d a group of fly genes needed for memory formation...
...ark populations worldwide are declining from destr...a rising global demand for shark products (mainly ...ly depleted and only a few stable or recovering, a...shark experts from the Pew Institute for Ocean Sci...ckwell Publishing, and being released today.* , ...
..., 2008 -Sustaining hope in the face of a chronic, ...clerosis (ALS) should be a goal of palliative care... from focusing on the self to concern for others, ...ue (Volume 8, Number 3) of Journal of Palliative M...d publication of Mary Ann Liebert, Inc ( www.liebe...
Other Biology News:CSHL scientists identify a mechanism that helps fruit flies lock-in memories 2Oceanic sharks worldwide at serious risk from high-seas fishing, rising demand for shark products 2Oceanic sharks worldwide at serious risk from high-seas fishing, rising demand for shark products 3Oceanic sharks worldwide at serious risk from high-seas fishing, rising demand for shark products 4Hope among patients with ALS may take a variety of forms 2
(Date:11/24/2009)...ewswire/--Twomoreprestigiousuniversitieshavejoined...dcareerssiteforlifescienceprofessionals. ,, Nor...bboard,joining28othermajorlifesciencetrainingInsti...m ,isonlyforpost-graduatesinthelifesciences.Whilet...et,BioCareerCenteristheonlyonethatserveslifescienc...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasd...stday"motionsbytheU.S.BankruptcyCourtfortheDistric...iledavoluntarypetitionfor,reliefunderChapter11ofth.... , TheordersissuedbytheBankruptcyCourtallowt...hapter11proceedings.Inparticular,the,companyreceiv...
(Date:11/24/2009)...ecently approved the Promega PowerPlex 16 HS Syste...rating DNA records for the National DNA Index Syst...WEB) -- The FBI recently approved the Promega Pow...participating in, or generating DNA records for, t...y contains more than seven million profiles and ha...
(Date:11/24/2009)...RNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: G...xecutiveChairman,willpresentatthe21stAnnualPiperJa...cember1,2009at10:00a.m.ET. ,, Toaccessthelivean...ttheInvestorRelationssectionofGenomicHealth,swebsi...ecttothewebsiteatleast15minutespriortothebeginning...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2
...h 13 ,Cellectis SA (NYSE: ALCLS ), a world leader...y that it filed a patent infringement lawsuit agai...es District Court for the,Eastern District of Nort...y making and selling certain meganucleases, Precis...lating to its proprietary meganuclease,recombinati...
.../ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI ...,medical device company, today announced the filin... and Management,s Discussion and Analysis,for the ...f its audited,consolidated financial statements fo... ended December 31, 2007, the Company,s net loss a...
...c.,(Nasdaq: BNVI ) announced today the appointmen...of Directors. Dr. Butler has extensive regulatory,...es, and in particular in,advancing cancer drug dev...d to have George on board as we move into a new,ph...linical trial,programs," said Isaac Cohen, O.M.D.,...
Other Biology Technology:Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 2Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 3Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 4Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 2Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 3Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 4Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 5Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 6Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 7Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 8Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 9George Butler Joins Bionovo's Board of Directors 2George Butler Joins Bionovo's Board of Directors 3
Rabbit Anti-Human ALPHA-2-ANTIPLASMIN Polyclonal Antibody, Unconjugated from AbD Serotec
...Plus DNA Polymerase with a proprietary thermostabl... fidelity than standard Taq DNA polymerase, Double...ies DNA templates >20kb, Concentration: 5U/ul, App...oning and mutagenesis We are part of Thermo Fisher...
...013) provides,researchers with a sensitive assay t... This fluorescence-based assay can detect,lysozyme...asures lysozyme activity on Micrococcus lysodeikti... that the fluorescence,is quenched. Lysozyme actio...
...y based on measurenment of enzyme activity of TRAP...er plate. The procedure includes two incubation st...yme reaction) separated by a washing step. The ass...maticaly active TRAP 5 (Tartrate Resistant Acid Ph...
Biology Products: